ReviewAnnals of hematology2022

Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence.

Sambhawana Bhandari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.